Inflammatory adenoma |
|
Hyper |
Hypo |
Hypo |
Restriction |
Hypo |
Hyper + |
Hyper |
Hyper/iso |
Hypo/hyper |
Signal heterogeneity, hypervascularity, intralesional hemorrhage |
HNF-1α-mutated adenoma |
Obesity, steatosis, diabetes, glycogenesis, exogenous steroids |
Iso/hyper |
Hyper |
Hypo |
No restriction |
Iso/hypo |
Hyper |
Hypo |
Hypo |
Hypo |
Fatty intralesional component |
β-catenin-mutated adenoma |
Hyper |
Hypo |
Hypo |
Restriction |
Hypo |
Hyper + |
Hyper |
Hyper/iso |
Hypo/hyper |
Intralesional hemorrhage, necrosis |
Unclassified adenoma |
|
|
|
|
|
|
|
|
|
|
Nonspecific patterns reported |
Focal nodular hyperplasia |
Exogenous steroids |
Iso |
Iso |
Iso |
No restriction |
Iso |
Hyper +++ |
Iso |
Iso |
Iso/hyper |
Signal homogeneity, hypervascularity, scar, iso/hyperintensity on HbP |
Large regenerative nodule |
Myeloproliferative and lymphoproliferative disorders, chronic vascular and rheumatologic syndromes |
Iso |
Iso |
Iso |
No restriction |
Iso |
Hyper ++ |
Iso |
Iso |
Iso/hyper |
Multiple lesions signal homogeneity, hypervascularity, scar, isohyperintensity on HbP |
HCC in noncirrhotic liver and FL-HCC |
Exogenous steroidenvironmental and dietary factors (aflatoxins and nitrosamine) |
Hyper |
Hypo |
Hypo |
Restriction |
Hypo |
Hyper ++ |
Hypo |
Hypo |
Hypo |
Signal heterogeneity, intralesional hemorrhage, signs of malignancy |
Cholangiocarcinoma |
Viral hepatic infection |
Hyper |
Hypo |
Hypo |
Restriction |
Hypo |
Hyper |
Hypo |
Hypo/iso |
Hypo/hyper |
Peripheral enhancement, peripheral washout, central pooling, signs of malignancy |
Primary lymphoma |
Epstein-Barr infection (EBV), HBV and/or HCV infections |
Iso/hyper |
Hypo |
Hypo |
Restriction |
Hypo |
Hyper |
Hypo |
Hypo |
Hypo |
Variable pattern, small lesions hypervascular, significant restriction |
Metastases |
Primary tumor, metastatic syndrome |
Hyper |
Hypo |
Hypo |
Restriction |
Hypo |
Hyper ++ |
Iso/hypo |
Hypo |
Hypo |
Multiple lesions hypervascularity, halo signs signs of malignancy |